4-broMo-N-isopropylpyridazin-3-aMine
- $330 - $4500
- Product name: 4-broMo-N-isopropylpyridazin-3-aMine
- CAS: 1396762-46-1
- MF: C7H10BrN3
- MW: 216.08
- EINECS:
- MDL Number:MFCD22570310
- Synonyms:4-broMo-N-isopropylpyridazin-3-aMine;3-Pyridazinamine, 4-bromo-N-(1-methylethyl)-
4 prices
Selected condition:
Brand
- Matrix Scientific
- TRC
Package
- 50mg
- 500mg
- 1g
- 5g
- ManufacturerMatrix Scientific
- Product number189215
- Product description4-Bromo-N-isopropylpyridazin-3-amine
- Packaging500mg
- Price$900
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number189215
- Product description4-Bromo-N-isopropylpyridazin-3-amine
- Packaging1g
- Price$1500
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number189215
- Product description4-Bromo-N-isopropylpyridazin-3-amine
- Packaging5g
- Price$4500
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB567295
- Product description4-bromo-N-isopropylpyridazin-3-amine
- Packaging50mg
- Price$330
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Matrix Scientific | 189215 | 4-Bromo-N-isopropylpyridazin-3-amine | 500mg | $900 | 2021-12-16 | Buy |
Matrix Scientific | 189215 | 4-Bromo-N-isopropylpyridazin-3-amine | 1g | $1500 | 2021-12-16 | Buy |
Matrix Scientific | 189215 | 4-Bromo-N-isopropylpyridazin-3-amine | 5g | $4500 | 2021-12-16 | Buy |
TRC | B567295 | 4-bromo-N-isopropylpyridazin-3-amine | 50mg | $330 | 2021-12-16 | Buy |
Properties
Boiling point :348.6±27.0 °C(Predicted)
Density :1.491±0.06 g/cm3(Predicted)
pka :2.95±0.10(Predicted)
Density :1.491±0.06 g/cm3(Predicted)
pka :2.95±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|